Precision BioSciences
DTIL
55 hedge funds and large institutions have $14.7M invested in Precision BioSciences in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 10 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 8
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
18% more capital inflows, than outflows
Capital inflows: $13.4M | Capital outflows: $11.3M
8% more funds holding
Funds holding: 51 → 55 (+4)
4.61% more ownership
Funds ownership: 45.97% → 50.58% (+4.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$5.59M |
| 2 |
Goldman Sachs
New York
|
+$2.09M |
| 3 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$1.13M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$719K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$487K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$6.32M |
| 2 |
Perceptive Advisors
New York
|
-$3.82M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$558K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$191K |
| 5 |
Blue Owl Capital Holdings
New York
|
-$181K |
DTIL Hedge Fund Activity: Q4 2024 in Review
55 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2024, worth a combined $14.7M — down 51% from $29.8M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new DTIL positions and 10 closed out — a net gain of 4 holders — while 18 added to existing stakes and 8 trimmed.
The largest buyer was Lynx1 Capital Management, opening a new position worth an estimated $5.59M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $6.32M sold.
- 55 institutional investors held Precision BioSciences (DTIL) as of Q4 2024, up from 51 in Q3 2024.
- Funds reported $14.7M of Precision BioSciences stock for Q4 2024, down 51% quarter-over-quarter.
- 14 funds opened new Precision BioSciences positions in Q4 2024 and 10 closed out, a net change of +4 holders.
- The largest Precision BioSciences buyer in Q4 2024 was Lynx1 Capital Management, an estimated $5.59M added.
- The largest Precision BioSciences seller in Q4 2024 was Janus Henderson Group, an estimated $6.32M sold.
Based on aggregated 13F filings for Q4 2024.